Educational information, not medical advice — ask your doctor or midwife.
Di Huang (Rehmannia glutinosa) is a perennial flowering plant native to China whose tuberous root has been a cornerstone of Traditional Chinese Medicine for over 2,000 years. It exists in two pharmacologically distinct processed forms: Sheng Di Huang (raw or dried root), considered cooling and used for heat-related conditions, and Shu Di Huang (wine-steamed prepared root), considered warming and tonic in nature. These processing methods meaningfully alter the phytochemical profile and clinical applications of the herb.
The primary bioactive constituents—particularly catalpol and the rehmannioside glycosides—appear to exert hypoglycemic effects by modulating insulin signaling pathways and improving peripheral glucose uptake. Acteoside and polysaccharides contribute anti-inflammatory and immunomodulatory activity, while oligosaccharides may support the gut microbiome. Catalpol has also been studied for neuroprotective and osteogenic (bone-forming) properties in laboratory models, though human translation remains preliminary.
In clinical practice and most human trials, Di Huang is rarely used as an isolated single herb—it is most commonly studied as part of the classical formula Liu Wei Di Huang Wan (Six-Ingredient Pill with Rehmannia), which complicates attribution of effects to Rehmannia alone. Standardized extracts providing defined catalpol percentages (commonly 0.5–1%) are increasingly available in Western markets. Traditional decoction remains standard in East Asian clinical settings.
Di Huang has been documented in Chinese materia medica since the Shennong Bencao Jing (Divine Farmer's Classic of Materia Medica, circa 200 CE), where it was classified among the superior (tonic) herbs. It became the foundational ingredient of Liu Wei Di Huang Wan, formulated by Song dynasty physician Qian Yi (1032–1113 CE) and still among the most widely prescribed herbal formulas in East Asia today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Di Huang (Rehmannia) is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.